Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $10.4 million.

  • Healthequity's Change in Accured Expenses fell 7225.8% to $10.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$31.6 million, marking a year-over-year decrease of 17437.76%. This contributed to the annual value of $17.8 million for FY2025, which is 50176.21% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Change in Accured Expenses is $10.4 million, which was down 7225.8% from $7.2 million recorded in Q3 2025.
  • Healthequity's Change in Accured Expenses' 5-year high stood at $45.7 million during Q1 2021, with a 5-year trough of -$42.2 million in Q2 2025.
  • In the last 5 years, Healthequity's Change in Accured Expenses had a median value of -$842000.0 in 2022 and averaged $570650.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 23743.11% in 2021, then soared by 2442662.34% in 2024.
  • Over the past 5 years, Healthequity's Change in Accured Expenses (Quarter) stood at -$3.8 million in 2021, then crashed by 99.06% to -$7.6 million in 2022, then soared by 97.97% to -$154000.0 in 2023, then soared by 24426.62% to $37.5 million in 2024, then tumbled by 72.26% to $10.4 million in 2025.
  • Its Change in Accured Expenses was $10.4 million in Q4 2025, compared to $7.2 million in Q3 2025 and -$42.2 million in Q2 2025.